Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,092 | 6,989 | 13,468 | 27,204 | 28,660 |
| TOTAL | $4,092 | $6,989 | $13,468 | $27,204 | $28,660 |
| Non-Current Assets | |||||
| Intangibles | 2 | 5 | 9 | 13 | 16 |
| TOTAL | $2 | $5 | $9 | $13 | $16 |
| Total Assets | $4,094 | $6,995 | $13,477 | $27,217 | $28,677 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,178 | 256 | 221 | 221 | 711 |
| Other current liabilities | 76 | 38 | 42 | 164 | 335 |
| TOTAL | $1,560 | $294 | $263 | $385 | $1,046 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 306 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,560 | $294 | $263 | $385 | $1,046 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,274 | 12,878 | 12,848 | 12,951 | 12,847 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -66,153 | -50,365 | -41,473 | -33,648 | -29,077 |
| TOTAL | $2,534 | $6,700 | $13,214 | $26,832 | $27,631 |
| Total Liabilities And Equity | $4,094 | $6,995 | $13,477 | $27,217 | $28,677 |